Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products
Rhea-AI Summary
Integrated Ventures (OTCQB: INTV) has announced its strategic entry into the health and wellness sector, focusing on the GLP-1 market. The company has established a new subsidiary, MedWell USA, , which will serve as a B2B Procurement Agent for pharmaceutical products, particularly in the medical weight loss market.
MedWell USA will target B2B clients such as medical offices, fitness facilities, and wellness clinics. CEO Steve Rubakh highlighted the significant growth potential in this sector, citing a UBS Securities forecast that projects the combined GLP-1 market for obesity and diabetes to reach $129 billion by 2029, with 40 million users and a 30% CAGR.
Integrated Ventures plans to establish two more subsidiaries and is finalizing strategic joint ventures to penetrate the health and wellness market effectively.
Positive
- Entry into the rapidly expanding health and wellness sector
- Focus on the booming GLP-1 market, projected to reach $129 billion by 2029
- Establishment of MedWell USA as a B2B Procurement Agent
- Plans for two additional subsidiaries to broaden weight loss operations
- Finalizing strategic joint ventures for market penetration
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, INTV declined 8.58%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
The initial phase of this transition will be led by the newly established subsidiary, MedWell
MedWell
Steve Rubakh, CEO of Integrated Ventures, comments: "This strategic entry represents a significant evolution for our company. The health and wellness sector offers immense growth potential, and we are eager to bring unique and impactful solutions (B2B and B2C) to market that will meet the critical needs of consumers seeking to improve their health and well-being. According to UB Securities (*) forecast, the combined GLP-1 market for obesity and diabetes will reach
In addition to launching MedWell
Integrated Ventures is committed to driving shareholder value by seizing high-growth opportunities within the health and wellness sector. The Company will provide regular updates as it advances its strategic plans and achieves key milestones.
(*) https://www.ubs.com/global/en/investment-bank/in-focus/2024/glp-1-a-medication.html
About Integrated Ventures, Inc:
Integrated Ventures, Inc. is a diversified holdings company that develops, acquires, operates, and invests in unique businesses. The Company's current operations include digital currency mining and hosting.
About MedWell
MedWell
Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.
Contact:
(215) 613-9898 sr@integratedventures.io
View original content:https://www.prnewswire.com/news-releases/integrated-ventures-announces-strategic-entry-into-health--wellness-industry-with-focus-on-glp-1-products-302232911.html
SOURCE Integrated Ventures Inc.